Critical Care Services Pharmacist Royal Manchester Children’s Hospital

Slides:



Advertisements
Similar presentations
National Reporting & Learning System (NRLS) Reporting systems are vital in providing a core of sound, representative information on which to base analysis.
Advertisements

Why documentation is relevant in implementing the NMP Dr Ross Maxwell Member, National Medicines Policy Committee Session 5: The Relevance of National.
CCHSA Accreditation: New Standards for Managing Medications
Medication Management
Community Pharmacy – Call to Action Derbyshire / Nottinghamshire Area Team.
The Patient Safety Challenge in the UK Dr Kevin Cleary Medical Director National Patient Safety Agency.
Standard 6: Clinical Handover
November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.
Medication Safety Standard 4 Part 1- Introduction Margaret Duguid, Pharmaceutical Advisor Graham Bedford, Medication Safety Program Manager Standard 4.
California Department of Public Health Loriann De Martini, Pharm.D. Chief Pharmaceutical Consultant Center for Healthcare Quality Medication Error Reduction.
TRAINING FOR ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN HOSPITALS JUNE 2014.
ESRD Network 6 5 Diamond Patient Safety Program
Implementation of Care Bundles in an Acute Children’s Care Setting ‘not without its challenges’! Paula McGrath Project Co-Ordinator Quality Department.
ACCORD Mark Roberts ACCORD Business Lead. Achieving Comprehensive Coordination in ORgan Donation EU funded Joint Action Joint Action led and coordinated.
Implementing and Evaluating a Program of Patient Safety Katherine Jones, PhD, PT Anne Skinner, RHIA Gary Cochran, PharmD Keith Mueller, PhD Supported by.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Driving Better Safer Care 25 April Background Established May 2007 Independent – reporting directly to Minister for Health and Children Functions.
Recommended by the Sentinel Event Alert Advisory Group NATIONAL PATIENT SAFETY GOALS FY 2009.
Farmleigh House, Dublin, June 29-30, 2006
Module 3. Session DCST Clinical governance
Sep-15 Provincial Collaboration: The BC Injury Prevention Leadership and Action Network (BCIPLAN) Dobmeier, Teresa 1, ▪ Herman, Matt 2 ; Scott, Vicky 2.
ACCORD Mark Roberts ACCORD Business Lead. Achieving Comprehensive Coordination in ORgan Donation EU funded Joint Action Joint Action led and coordinated.
Clinical Risk Unit University College London International Perspectives Feedback from the review board Charles Vincent Clinical Risk Unit University College.
Primary Care Trigger Tool Manaia Health PHO Linda Holman Quality Leader.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Leroy Edozien Consultant in Obstetrics & Gynaecology St Mary’s Hospital, Manchester, UK.
Delivering a Healthy WA Minimising Medication Errors: A new approach to medication safety WATAG Seminar Nick May Staff Development Educator Royal Perth.
National Patient Safety Programme Clydebank 9 th November 2007.
Paediatric International Patient Safety and Quality Community (PIPSQC)
Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)
Copyright © 2006 Elsevier, Inc. All rights reserved Chapter 22 Quality Patient Care.
S.A.F.E Situation Awareness For Everyone
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
National Strategy for Quality Improvement in Health Care June 15, 2011 Kana Enomoto Director Office of Policy, Planning, and Innovation.
Surgical safety is a serious public health issue About 234 million operations are done globally each year A rate of % deaths and 3-16% complications.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Surgical safety is a serious public health issue About 234 million operations are done globally each year A rate of % deaths and 3-16% complications.
Linking the learning to the National Standards for Safer Better Healthcare Joan Heffernan Inspector Manager Regulation – Healthcare Health Information.
8 Medication Errors and Prevention.
Governance & Standards What is happening internationally Triona Fortune, March 2016.
HEALTH AND CARE STANDARDS APRIL Background Ministerial commitment 2013 – Safe Care Compassionate Care Review “Doing Well Doing Better” Standards.
National Accreditation Forum, Vic Health Ms Margaret Banks, A/Senior Operations Manager 25 July 2011.
We’re counting the benefits of EPR Find out at: epr.this.nhs.uk We’re counting the benefits of EPR Find out at: epr.this.nhs.uk The introduction of EPR.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
HSE - Prevention of Falls A Joint Presentation by: Antoinette Malone, Clinical Placement Co-Ordinator Nursing Practice Development Department Connolly.
Insert name of presentation on Master Slide Annual Quality Framework Quality & Safety improvement Reporting.
The effectiveness of interventions in preventing medication errors in patient controlled analgesia among post-surgical patients: A systematic review Ms.
A practical guide for clubs
Title of the Change Project
Hospital Engagement Network
T. Cameron1,2,3,4,8,9, Dr D. Roberson1,5,6, Dr S. Warrilow1,4, Dr M
Professor James Ferguson,
Risk Communication in Medicines
Florida’s Hospitals: Five Years of Improved Quality
An Integrated Risk Management & Safety Program: IRMSP
Evaluating Australia‘s National Strategy for Quality Use of Medicines
Mary Alexander, MA, RN, CRNI®, CAE, FAAN Chief Executive Officer
Clinical practice guidelines and Clinical audit
What is a Learning Collaborative?
Powys teaching Health Board
EDC ©2016. All rights reserved.
Membership Management Highlights
68.3 million errors (28% of total) cause moderate or serious harm
ايمني بيمار PATIENT SAFETY حق بيمار و مسئوليت ما
The 5th Annual Lorraine Tregde Patient Safety Leadership Conference “The Will to Pursue Excellence” June 14, 2012.
Chapter 10 Quality and Safety
Medicines Safety Programme
Pharmacy practice and the healthcare system Ola Ali Nassr
8 Medication Errors and Prevention.
Presentation transcript:

Critical Care Services Pharmacist Royal Manchester Children’s Hospital Afia Manaf Critical Care Services Pharmacist Royal Manchester Children’s Hospital

Learning Objectives Recognise who MiST are and their relevance to UK paediatric hospitals Background to the formation of MiST Understand NCC MERP Medication Error Index and its application in clinical practice Discuss current and future risk reduction strategies to minimise medication errors

MiST - Background MiST – Making it Safer Together A new paediatric patient safety collaborative – new alliance of hospitals Share a vision of achieving harm free paediatric care through a process of sustained year on year reduction in adverse events.

MiST - Background MiST collaborative was born following a meeting of senior clinicians and managers in late 2013 Came together to discuss how a UK model of the USA project could be established Open forum for the sharing of ideas & methodology for enhancing patient safety

MiST - Background Each participating centre is asked to collect data in the following areas for pilot work in the UK: Adverse Drug Events Readmissions Central Line Associated Blood Stream Infections

MiST - Background Results are used to promote discussion and enable identification of centres who perform strongly & those who have made major improvements in performance. These centres are encouraged to share their care bundles, guidelines etc. for other organisations to learn from.

MiST - Background The results are NOT used for benchmarking and there is no place in the collaboration for competition Simply for sharing ideas and improving practice The goal for each organisation is a year on year improvement The current membership is largely drawn from tertiary children’s centres

MiST - Adverse Drug Events NCCMERP – National Coordinating Council for Medication Error Reporting and Prevention is an independent body composed of 27 national organisations Formed in the United States in 1995 National healthcare organisations meet, collaborate & cooperate to address the interdisciplinary causes of errors and to promote the safe use of medicines

MiST - Adverse Drug Events NCCMERP Vision and Mission Vision No patient will be harmed by a medication error Mission Maximise the safe use of medicines and to increase awareness of medication errors through open communication, increased reporting and promotion of medication error prevention strategies

MiST - Adverse Drug Events NCCMERP Goals & Objectives Promote the development and use of reporting and evaluating systems by individual health care organisations Promote reporting to a national system for review, analysis and development of recommendations Examine and evaluate the cause of errors

MiST - Adverse Drug Events NCCMERP Goals & Objectives Increase awareness and methods of prevention throughout the health care system Recommend strategies for system modifications, practice standards and guidelines, changes in packaging and labelling

MiST - Adverse Drug Events NCCMERP Goals and Objectives Promote reporting, discussion and communication about safe medicines use, error prone processes & error prevention strategies Disseminate NCCMERP’s recommendations Collaborate with other interested stakeholders to address special topics

NCCMERP Types of Medication Errors The council recognised the need for a standardised method of categorising medication errors in order to meet their goals and objectives The council defines a medication error as:

Medication error definition “A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient or consumer. Such events may be related to professional practice, health care products, procedures and systems including prescribing, ordering, labelling, packaging, compounding, dispensing, distribution, administration, education, monitoring and use”

NCCMERP Types of Medication Errors The council encourages medication error researchers, software developers and institutions to use this standard definition The NCC MERP adopted a medication error index in 1996 which classifies errors according to the severity of the outcome

NCC MERP Index for categorising errors Category A - No Error Error, No Harm Category B – Error did not reach the patient Category C – Reached patient but did not cause harm Category D – Reached patient and required monitoring to confirm that it resulted in no harm

NCC MERP Index for categorising errors Error, Harm Category E – error may have resulted in temporary harm & required intervention Category F – error may resulted in temporary harm and initial or prolonged hospitalisation Category G – error resulted in permanent patient harm Category H – error required intervention to sustain life

NCC MERP Index for categorising errors Error, Death Category I - error contributed or resulted in patient’s death “A good performing institution will probably have a high incidence of errors in category A-D, fewer in E-H and no category I errors”

Advantages of NCC MERP Index Various systems available for reporting medication errors e.g. Safeguarding, Datix CMFT uses Safeguarding

Advantages of NCC MERP Index vs. Safeguarding Safeguarding reporting system not specific to medication errors Doesn’t capture information in detail Doesn’t capture extent of interventions Doesn’t indicate if error has been identified pre or post administration Doesn’t capture outcome details

Advantages of NCC MERP Index MERP index will allow standardisation across collaborating hospitals Promotes sharing of ideas Promotes improved medication practice and implementation of safe strategies Create a culture for learning, feedback and support Provides greater detail and quality of information

NCC MERP Index Useful to UK paediatric Hospitals? Operates on a larger scale in the US Publish alerts nationally No real benefit unless other centres are collaborating

Future Goals for MiST MiST will grow and develop nationally More paediatric hospitals will participate! Hospitals will upload care bundles and guidelines onto website Share ideas to enhance patient safety